Skip to main content
Hester Biosciences Ltd logo

Hester Biosciences Ltd — Investor Relations & Filings

Ticker · HESTERBIO ISIN · INE782E01017 LEI · 984500836B9EB1DC4935 BSE.NS Manufacturing
Filings indexed 672 across all filing types
Latest filing 2021-07-24 AGM Information
Country IN India
Listing BSE.NS HESTERBIO

About Hester Biosciences Ltd

https://www.hester.in/

Hester Biosciences Ltd specializes in the development, manufacturing, and marketing of animal healthcare products. The company primarily focuses on two segments: poultry healthcare and livestock healthcare. Its extensive product portfolio includes a wide range of live and inactivated vaccines, as well as health products such as therapeutics, herbal supplements, and disinfectants. Hester is recognized for its significant contributions to global animal disease control programs, particularly in the eradication of Peste des Petits Ruminants (PPR) and Brucellosis. The company operates advanced manufacturing facilities and maintains a robust distribution network to serve domestic and international markets. By leveraging research and development, Hester provides diagnostic services and technical support to enhance animal productivity and welfare. Its commitment to quality and innovation has established it as a key provider of biologicals and health solutions for the veterinary sector.

Recent filings

Filing Released Lang Actions
Copy of Newspaper Publication
AGM Information Classification · 100% confidence The document is a notice of the 34th Annual General Meeting (AGM) of Hester Biosciences Limited, including details about the meeting date, e-voting information, book closure period, and dividend recommendation. It references the Annual Report 2020-21 being sent electronically but does not contain the report itself. The document is primarily a formal announcement and notice related to the AGM, including voting instructions and regulatory compliance information. It is not the Annual Report or any other detailed financial report. Therefore, the document fits the category of AGM Information (AGM-R). The document length is sufficient and contains detailed AGM notice content, not just a brief announcement, confirming it is an AGM Information filing.
2021-07-24 English
Book Closure
Annual Report Classification · 100% confidence The document is a detailed communication dated 23 July 2021, addressed to stock exchanges, announcing the 34th Annual General Meeting (AGM) and simultaneously submitting the Annual Report for the financial year 2020-21. The text includes extensive content typical of an Annual Report: corporate overview, financial highlights, management discussion, statutory reports, and financial statements. The document length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement or notice. The presence of detailed financial data, management messages, and comprehensive corporate information confirms this is the actual Annual Report filing. Therefore, the correct classification is Annual Report (10-K).
2021-07-24 English
Shareholders meeting
Annual Report Classification · 100% confidence The document is a detailed communication dated 23 July 2021, addressed to stock exchanges, announcing the 34th Annual General Meeting (AGM) and providing the Annual Report for the financial year 2020-21. It includes extensive content typical of an Annual Report such as corporate overview, financial highlights, management discussion, statutory reports, and financial statements. The document is about 15,000 characters long, indicating it is a full report rather than a brief announcement. The text explicitly mentions 'Annual Report 2020-21' multiple times and contains comprehensive financial and operational information. Therefore, this document is the full Annual Report for the fiscal year 2020-21, not just an announcement or a summary.
2021-07-23 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, confirming details of securities dematerialised/rematerialised during the quarter ended 30.06.2021. It is addressed to stock exchanges and includes a confirmation letter from the Registrar and Share Transfer Agent. The document is short (2959 characters) and primarily serves as a regulatory compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements or detailed financial data. Therefore, it fits best under Regulatory Filings (RNS), which covers officer certifications and compliance documents that do not qualify as full reports or announcements.
2021-07-07 English
Related Party Transactions
Regulatory Filings Classification · 95% confidence The document is a disclosure of Related Party Transactions for the half year ended 31.03.2021, submitted to stock exchanges as per SEBI regulations. It contains detailed financial data on transactions and balances with related parties for the half year period. This is a regulatory compliance disclosure related to financial transactions but is not a full financial report like an Annual or Interim Report. It is not an announcement of a report but the actual disclosure document itself. Such disclosures typically fall under Regulatory Filings (RNS) as they are compliance documents submitted to exchanges and regulators, and do not constitute standalone financial reports like 10-K or IR. The document length (5143 characters) and content confirm it is a detailed regulatory filing rather than a brief announcement or a full financial report.
2021-07-06 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about the closure of the trading window pursuant to SEBI regulations related to insider trading. It references the upcoming financial results for the quarter ended 30.06.2021 but does not contain any financial data or detailed report. The document is essentially an announcement related to regulatory compliance and trading restrictions, not a financial report or earnings release. Given its short length (1210 characters) and content, it fits best under Regulatory Filings (RNS) as a general regulatory announcement.
2021-06-29 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.